This is the authors' abstract. We don't add key points for this paper.
The aim of this review is to present some of the recent publications on cannabidiol (CBD; 2), a major non-psychoactive constituent of Cannabis, and to give a general overview. Special emphasis is laid on biochemical and pharmacological advances, and on novel mechanisms recently put forward, to shed light on some of the pharmacological effects that can possibly be rationalized through these mechanisms. The plethora of positive pharmacological effects observed with CBD make this compound a highly attractive therapeutic entity.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mechoulam et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: